|HDST -- Israel Stock|| |
ILS 516.00 24.90 5.07%
Hadasit Bio Holdings Ltd diagnostics interface makes it easy to digest most current publicly released information about Hadasit Bio as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Hadasit Bio price relationship with some important fundamental indicators such as market cap and management efficiency.
Hadasit Bio Note
The company had not issued any dividends in recent years. Hadasit Bio Holdings Ltd had 1:5 split on 2016-07-24. Hadasit Bio-Holdings, Ltd., through its subsidiaries, engages in the research and development in medical and biotechnology fields in Israel. Hadasit Bio-Holdings, Ltd. was founded in 2005 and is based in Jerusalem, Israel. Hadasit Bio operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. To learn more about HADASIT BIO HLDGS call Michel Habib at 972 2 677 8757 or check out http://www.hbl.co.il.
Hadasit Bio Holdings Alerts
|Hadasit Bio Holdings is not yet fully synchronised with the market data|
|Hadasit Bio Holdings generates negative expected return over the last 30 days|
|HADASIT BIO HLDGS has accumulated about 45.1M in cash with (20.72M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.7. |
The company currently falls under 'Micro-Cap' category with current market capitalization of 53.95M.
The company has Profit Margin (PM) of 536.4 %
which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large.
Hadasit Bio Holdings Ltd has return on total asset (ROA) of (23.39) %
which means that it has lost $23.39 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (27.5) %
meaning that it generated substantial loss on money invested by shareholders.
Hadasit Bio Technical and Predictive Indicators